This study provides a preliminary foundation based on the in vitro inhibition of AChE, a key biomarker in the treatment of Alzheimer’s disease, and the AChE-inhibitory activity and moderate antioxidant properties of the EOs open new possibilities for future research. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.